Kirsner RS - Search Results

1

Pyoderma Gangrenosum in a Patient with Bruton's X-linked Agammaglobulinemia: Shared Pathogenesis of Altered Tumor Necrosis Factor Alpha?

Schwartzfarb EM, Weir D, Conlan WA, Romanelli P, Kirsner RS. Schwartzfarb EM, et al. Among authors: kirsner rs. J Clin Aesthet Dermatol. 2008 May;1(1):26-9. J Clin Aesthet Dermatol. 2008. PMID: 21103306 Free PMC article.

2

Understanding scarring: scarless fetal wound healing as a model.

Schwartzfarb E, Kirsner RS. Schwartzfarb E, et al. Among authors: kirsner rs. J Invest Dermatol. 2012 Feb;132(2):260. doi: 10.1038/jid.2011.444. J Invest Dermatol. 2012. PMID: 22241439 Free article. No abstract available.

3

Insights in Behçet's disease: has a target antigen been identified?

Schwartzfarb E, Kirsner RS. Schwartzfarb E, et al. Among authors: kirsner rs. J Invest Dermatol. 2012 Mar;132(3 Pt 1):505. doi: 10.1038/jid.2012.8. J Invest Dermatol. 2012. PMID: 22327260 Free article. No abstract available.

4

Tumor necrosis factor-alfa in nonhealing venous leg ulcers.

Charles CA, Romanelli P, Martinez ZB, Ma F, Roberts B, Kirsner RS. Charles CA, et al. Among authors: kirsner rs. J Am Acad Dermatol. 2009 Jun;60(6):951-5. doi: 10.1016/j.jaad.2008.09.012. Epub 2009 Apr 2. J Am Acad Dermatol. 2009. PMID: 19344978

5

Herpes simplex virus: a histopathologic study of the depth of herpetic wounds.

Patel AR, Romanelli P, Roberts B, Kirsner RS. Patel AR, et al. Among authors: kirsner rs. Int J Dermatol. 2009 Jan;48(1):36-40. doi: 10.1111/j.1365-4632.2009.03788.x. Int J Dermatol. 2009. PMID: 19126048

6

Telangiectasia macularis eruptiva perstans with an associated myeloproliferative disorder.

Martin LK, Romanelli P, Ahn YS, Kirsner RS. Martin LK, et al. Among authors: kirsner rs. Int J Dermatol. 2004 Dec;43(12):922-4. doi: 10.1111/j.1365-4632.2004.02249.x. Int J Dermatol. 2004. PMID: 15569020

7

Use of SCORTEN to accurately predict mortality in patients with toxic epidermal necrolysis in the United States.

Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Trent JT, et al. Among authors: kirsner rs. Arch Dermatol. 2004 Jul;140(7):890-2. doi: 10.1001/archderm.140.7.890. Arch Dermatol. 2004. PMID: 15262712 No abstract available.

8

Scoring With SCORTEN-Reply.

Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Trent JT, et al. Among authors: kirsner rs. Arch Dermatol. 2003 Sep 1;139(9):1215-1216. doi: 10.1001/archderm.139.9.1215-b. Arch Dermatol. 2003. PMID: 28241278 No abstract available.

9

Analysis of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis using SCORTEN: The University of Miami Experience.

Trent JT, Kirsner RS, Romanelli P, Kerdel FA. Trent JT, et al. Among authors: kirsner rs. Arch Dermatol. 2003 Jan;139(1):39-43. doi: 10.1001/archderm.139.1.39. Arch Dermatol. 2003. PMID: 12533162

10

Adalimumab treatment leads to reduction of tissue tumor necrosis factor-alpha correlated with venous leg ulcer improvement: a pilot study.

Fox JD, Baquerizo-Nole KL, Keegan BR, Macquhae F, Escandon J, Espinosa A, Perez C, Romanelli P, Kirsner RS. Fox JD, et al. Among authors: kirsner rs. Int Wound J. 2016 Oct;13(5):963-6. doi: 10.1111/iwj.12497. Epub 2015 Sep 24. Int Wound J. 2016. PMID: 26399369 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

574 results

Search Page